Tobin Schilke - Chief Financial Officer at Crinetics Pharmaceuticals, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Financial Officer
Issuer Symbol
CRNX on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Tobin Schilke since 03 Mar 2025

Holdings reported by Tobin Schilke for Crinetics Pharmaceuticals, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 84,834 $4,724,405 $55.69 23 Feb 2026 Direct
Stock Option (Right to Buy) 50,000 23 Feb 2026 Direct Common Stock

Transactions reported by Tobin Schilke for Crinetics Pharmaceuticals, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.